THK (6481) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
11 Nov, 2025Executive summary
Revenue for the nine months ended September 30, 2025, increased 1.2% year-over-year to ¥268,227 million, driven by recovery in industrial machinery demand, especially in China and the US.
Operating income declined 24.7% year-over-year to ¥9,728 million, impacted by structural reform costs and U.S. tariffs.
Profit attributable to owners of the parent fell 42.8% year-over-year to ¥5,254 million, reflecting higher costs and equity-method losses.
Comprehensive loss of ¥1,715 million, compared to a comprehensive income of ¥14,482 million in the prior year period, mainly due to negative foreign currency translation effects.
Financial highlights
Gross profit was ¥60,012 million, nearly flat year-over-year, with a gross margin of 22.4%.
Basic earnings per share dropped to ¥46.38 from ¥74.96 year-over-year.
Total assets decreased to ¥525,086 million from ¥567,418 million at the previous year-end.
Total equity declined to ¥320,556 million, with equity attributable to owners at ¥316,592 million.
Outlook and guidance
Full-year 2025 revenue forecast is ¥360,000 million, up 2.1% year-over-year.
Operating income projected at ¥16,000 million (down 7.8%), and profit attributable to owners at ¥10,000 million (down 4.2%).
Dividend per share projected at ¥246.00 for 2025, based on an 8% dividend on equity policy.
Latest events from THK
- Major loss from business transfer drives net loss, but strong FY2026 recovery forecast.6481
Q4 202518 Mar 2026 - Revenue and profit declined, but China and Asia showed growth as equity fell on buybacks.6481
Q2 202518 Mar 2026 - Revenue was stable but profit fell; FY2025 outlook expects strong profit recovery.6481
Q4 202418 Mar 2026 - Revenue and profit fell year-over-year, but recovery and new product initiatives support outlook.6481
Q2 202418 Mar 2026 - Profit plunged despite stable revenue, but full-year outlook and dividend were raised.6481
Q1 202518 Mar 2026 - Profit and revenue fell year-over-year, with margin pressure and cautious full-year outlook.6481
Q3 202418 Mar 2026